Atrial fibrillation (AF) is observed in approximately one third of patients undergoing transcatheter aortic valve implantation (TAVI), most often in need for anticoagulation due to their high stroke risk. On… Click to show full abstract
Atrial fibrillation (AF) is observed in approximately one third of patients undergoing transcatheter aortic valve implantation (TAVI), most often in need for anticoagulation due to their high stroke risk. On the other hand, hemorrhage in this specific group of patients is related to worse outcome.
               
Click one of the above tabs to view related content.